Self-managed medication abortion outcomes: results from a prospective pilot study
- PMID: 33109230
- PMCID: PMC7588945
- DOI: 10.1186/s12978-020-01016-4
Self-managed medication abortion outcomes: results from a prospective pilot study
Abstract
Background: To evaluate the feasibility of conducting a prospective study to measure self-managed medication abortion outcomes, and to collect preliminary data on safety and effectiveness of self-managed medication abortion, we recruited callers to accompaniment groups (volunteer networks that provide counselling through the out-of-clinic medication abortion process by trained counselors over the phone or in-person).
Methods: In 2019, we enrolled callers to three abortion accompaniment groups in three countries into a prospective study on the safety and effectiveness of self-managed medication abortion with accompaniment support. Participants completed up to five interview-administered questionnaires from baseline through 6-weeks after taking the pills. Primary outcomes included: (1) the number of participants enrolled in a 30-day period, (2) the proportion that had a complete abortion; and (3) the proportion who experienced any warning signs of potential or actual complications.
Results: Over the 30-day recruitment period, we enrolled 227 participants (95% of those invited), and retained 204 participants (90%) for at least one study follow-up visit. At the 1-week follow-up, two participants (1%) reported a miscarriage prior to taking the pills, and 202 participants (89% of those enrolled and 99% of those who participated in the 1-week survey) had obtained and taken the medications. Three weeks after taking the medications, 192 (95%) participants reported feeling that their abortion was complete. Three (1.5%) received a surgical intervention, two (1%) received antibiotics, and five (3%) received other medications. Participants did not report any major adverse events.
Conclusion: These results establish the feasibility of conducting prospective studies of self-managed medication abortion in legally restrictive settings. Further, the high effectiveness of self-managed medication abortion with accompaniment support reported here is consistent with high levels of effectiveness reported in prior studies. Trial registration ISRCTN95769543.
Keywords: Abortion; Accompaniment; Africa; Mifepristone; Misoprostol; Self-managed abortion; South America; Southeast Asia.
Conflict of interest statement
We have no competing interests to declare.
Figures
Similar articles
-
Effectiveness of self-managed medication abortion with accompaniment support in Argentina and Nigeria (SAFE): a prospective, observational cohort study and non-inferiority analysis with historical controls.Lancet Glob Health. 2022 Jan;10(1):e105-e113. doi: 10.1016/S2214-109X(21)00461-7. Epub 2021 Nov 18. Lancet Glob Health. 2022. PMID: 34801131 Free PMC article.
-
Effectiveness of Self-Managed Medication Abortion Between 9 and 16 Weeks of Gestation.Obstet Gynecol. 2023 Aug 1;142(2):330-338. doi: 10.1097/AOG.0000000000005266. Epub 2023 Jul 5. Obstet Gynecol. 2023. PMID: 37411022
-
Studying Accompaniment model Feasibility and Effectiveness (SAFE) Study: study protocol for a prospective observational cohort study of the effectiveness of self-managed medication abortion.BMJ Open. 2020 Nov 19;10(11):e036800. doi: 10.1136/bmjopen-2020-036800. BMJ Open. 2020. PMID: 33444174 Free PMC article.
-
Comparison of vaginal and buccal misoprostol after mifepristone for medication abortion through 70 days of gestation: A retrospective chart review.Contraception. 2022 Nov;115:62-66. doi: 10.1016/j.contraception.2022.06.012. Epub 2022 Jun 28. Contraception. 2022. PMID: 35772525 Review.
-
Medication abortion.Clin Obstet Gynecol. 2009 Jun;52(2):140-50. doi: 10.1097/GRF.0b013e3181a2b026. Clin Obstet Gynecol. 2009. PMID: 19407520 Review.
Cited by
-
Medication Abortion Safety and Effectiveness With Misoprostol Alone.JAMA Netw Open. 2023 Oct 2;6(10):e2340042. doi: 10.1001/jamanetworkopen.2023.40042. JAMA Netw Open. 2023. PMID: 37889485 Free PMC article.
-
Inequities in safe abortion: women's care trajectories in Abuja and Lagos, Nigeria.BMC Public Health. 2025 Aug 21;25(1):2869. doi: 10.1186/s12889-025-23889-5. BMC Public Health. 2025. PMID: 40841611 Free PMC article.
-
"I just have to hope that this abortion should go well": Perceptions, fears, and experiences of abortion clients in Nigeria.PLoS One. 2022 Feb 7;17(2):e0263072. doi: 10.1371/journal.pone.0263072. eCollection 2022. PLoS One. 2022. PMID: 35130269 Free PMC article.
-
Effectiveness of self-managed medication abortion with accompaniment support in Argentina and Nigeria (SAFE): a prospective, observational cohort study and non-inferiority analysis with historical controls.Lancet Glob Health. 2022 Jan;10(1):e105-e113. doi: 10.1016/S2214-109X(21)00461-7. Epub 2021 Nov 18. Lancet Glob Health. 2022. PMID: 34801131 Free PMC article.
-
Seeking abortion medications online: experiences from a mystery client study in Colombia.BMJ Open. 2025 Jan 20;15(1):e086404. doi: 10.1136/bmjopen-2024-086404. BMJ Open. 2025. PMID: 39832976 Free PMC article.
References
-
- Moseson H, Herold S, Filippa S, Barr-Walker J, Baum SE, Gerdts C. Self-managed abortion: a systematic scoping review. Best Pract Res Clin Obstetr Gynaecol. 2020;63:87–110. - PubMed
-
- WHO. Medical management of abortion. Geneva: World Health Organization; 2018. Report No.: ISBN 978-92-4-155040-6
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical